|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unité d'Immunologie Virale, Institut Pasteur, Paris, France (B.L., T.P., K.B., Y.P., I.S., F.B.); Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (S.B., C.B., G.V., M.P.), Service de Génétique Médicale (G.V.), Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium; Euroscreen, Gosselies, Belgium (E.L.P.); and Department of Immunology, Georg-August-University, Göttingen, Germany (M.O.)
CC chemokine receptor 5 (CCR5) is a G protein-coupled receptor that governs migration of leukocytes and serves as a coreceptor for the R5 tropic strains of human immunodeficiency virus (HIV). CCR5-mediated signaling in response to CC chemokines relies on G protein activation. Desensitization, which rapidly turns off G protein-dependent signaling, involves phosphorylation of CCR5 that promotes interaction of the receptor with
-arrestins for endocytosis. Whether coupling to G proteins, desensitization, and endocytosis of CCR5 require the same structural determinants remains a matter of investigation. Here, we show that CCR5 displayed agonist-independent coupling to G proteins. This constitutive activity of the receptor was abrogated by TAK779 (N,N-dimethyl-N-[4-[[[2-(4-methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbonyl]amino]benzyl]tetrahydro-2H-pyran-4-aminium chloride), a nonpeptidic CCR5 ligand that inhibits HIV infection and was found to depend on the integrity of the Asp-Arg-Tyr (DRY) motif. Changing Arg-126 by the neutral residue Asn (R126N-CCR5 mutant) abolished CCR5-mediated activation of G proteins, either constitutively or in response to agonists. In contrast, R126N-CCR5 not only retained agonist-promoted phosphorylation and
-arrestin-dependent endocytosis but also displayed a higher basal phosphorylation than wild-type CCR5. Expression of
-arrestin in R126N-CCR5-expressing cells resulted in receptor down-regulation, thereby suggesting that R126N-CCR5 spontaneously interacts with
-arrestins. However, although expression of
-arrestin favored wild-type CCR5-mediated chemotaxis, it failed to promote migration of cells expressing R126N-CCR5. Overall, these data indicate that structural requirements for CCR5-mediated activation of G proteins, albeit not involved in receptor desensitization and internalization, are needed for
-arrestin-mediated chemotaxis. These results have implications for how distinct biological responses of CCR5 might rely on a different set of receptor conformations.
Received for publication November 26, 2004.
Accepted for publication March 10, 2005.
Address correspondence to: Dr. Françoise Bachelerie, Institut Pasteur, Unité d'Immunologie Virale, 28 rue du Dr Roux, 75015 Paris, France. E-mail: fbachele{at}pasteur.fr.
This article has been cited by other articles:
![]() |
D. Sohy, H. Yano, P. de Nadai, E. Urizar, A. Guillabert, J. A. Javitch, M. Parmentier, and J.-Y. Springael Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of "Selective" Antagonists J. Biol. Chem., November 6, 2009; 284(45): 31270 - 31279. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Sherrill, M. P. Stropes, O. D. Schneider, D. E. Koch, F. M. Bittencourt, J. L. C. Miller, and W. E. Miller Activation of Intracellular Signaling Pathways by the Murine Cytomegalovirus G Protein-Coupled Receptor M33 Occurs via PLC-{beta}/PKC-Dependent and -Independent Mechanisms J. Virol., August 15, 2009; 83(16): 8141 - 8152. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Turu, P. Varnai, P. Gyombolai, L. Szidonya, L. Offertaler, G. Bagdy, G. Kunos, and L. Hunyady Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT1 Angiotensin and Other Gq/11 Protein-coupled Receptors J. Biol. Chem., June 19, 2009; 284(25): 16914 - 16921. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Levoye, K. Balabanian, F. Baleux, F. Bachelerie, and B. Lagane CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling Blood, June 11, 2009; 113(24): 6085 - 6093. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Camargo, M. P. Quinones, S. Mummidi, S. Srinivas, A. A. Gaitan, K. Begum, F. Jimenez, S. VanCompernolle, D. Unutmaz, S. S. Ahuja, et al. CCR5 Expression Levels Influence NFAT Translocation, IL-2 Production, and Subsequent Signaling Events during T Lymphocyte Activation J. Immunol., January 1, 2009; 182(1): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Hartmann, V. Grabovsky, R. Pasvolsky, Z. Shulman, E. C. Buss, A. Spiegel, A. Nagler, T. Lapidot, M. Thelen, and R. Alon A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells J. Leukoc. Biol., October 1, 2008; 84(4): 1130 - 1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Otero, P. S. Eisele, K. Schaeuble, M. Groettrup, and D. F. Legler Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis J. Cell Sci., August 15, 2008; 121(16): 2759 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome Blood, July 1, 2008; 112(1): 34 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Verzijl, S. Storelli, D. J. Scholten, L. Bosch, T. A. Reinhart, D. N. Streblow, C. P. Tensen, C. P. Fitzsimons, G. J. R. Zaman, J. E. Pease, et al. Noncompetitive Antagonism and Inverse Agonism as Mechanism of Action of Nonpeptidergic Antagonists at Primate and Rodent CXCR3 Chemokine Receptors J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 544 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pastore, R. Nedellec, A. Ramos, O. Hartley, J. L. Miamidian, J. D. Reeves, and D. E. Mosier Conserved Changes in Envelope Function during Human Immunodeficiency Virus Type 1 Coreceptor Switching J. Virol., August 1, 2007; 81(15): 8165 - 8179. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Rovati, V. Capra, and R. R. Neubig The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State Mol. Pharmacol., April 1, 2007; 71(4): 959 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Berchiche, K. Y. Chow, B. Lagane, M. Leduc, Y. Percherancier, N. Fujii, H. Tamamura, F. Bachelerie, and N. Heveker Direct Assessment of CXCR4 Mutant Conformations Reveals Complex Link between Receptor Structure and G{alpha}i Activation J. Biol. Chem., February 23, 2007; 282(8): 5111 - 5115. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gaibelet, T. Planchenault, S. Mazeres, F. Dumas, F. Arenzana-Seisdedos, A. Lopez, B. Lagane, and F. Bachelerie CD4 and CCR5 Constitutively Interact at the Plasma Membrane of Living Cells: A CONFOCAL FLUORESCENCE RESONANCE ENERGY TRANSFER-BASED APPROACH J. Biol. Chem., December 8, 2006; 281(49): 37921 - 37929. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Michel, K. Ganter, S. Venzke, J. Bitzegeio, O. T. Fackler, and O. T. Keppler The Nef Protein of Human Immunodeficiency Virus Is a Broad-Spectrum Modulator of Chemokine Receptor Cell Surface Levels That Acts Independently of Classical Motifs for Receptor Endocytosis and G{alpha}i Signaling Mol. Biol. Cell, August 1, 2006; 17(8): 3578 - 3590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Springael, P. N. Le Minh, E. Urizar, S. Costagliola, G. Vassart, and M. Parmentier Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers Mol. Pharmacol., May 1, 2006; 69(5): 1652 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huttenrauch, B. Pollok-Kopp, and M. Oppermann G Protein-coupled Receptor Kinases Promote Phosphorylation and {beta}-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers J. Biol. Chem., November 11, 2005; 280(45): 37503 - 37515. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Balabanian, B. Lagane, S. Infantino, K. Y. C. Chow, J. Harriague, B. Moepps, F. Arenzana-Seisdedos, M. Thelen, and F. Bachelerie The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes J. Biol. Chem., October 21, 2005; 280(42): 35760 - 35766. [Abstract] [Full Text] [PDF] |
||||